Large-scale testing (Phase 3)Active Not RecruitingNCT05499390What this trial is testingAK112 in Advanced Non-Small Cell Lung CancerWho this might be right forAdvanced Non-small-cell Lung Cancer Akeso 398
Not applicableStudy completedNCT00068497What this trial is testingGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04036682What this trial is testingA Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerEGFR Exon 20 Mutation Cullinan Therapeutics Inc. 284
Early research (Phase 1)Study completedNCT00005023What this trial is testingVaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerWho this might be right forBreast CancerLung CancerOvarian Cancer University of Washington
Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Study completedNCT00252746What this trial is testingZD6474 Phase IIa Dose Finding Multicentre StudyWho this might be right forNon Small Cell Lung Carcinoma Genzyme, a Sanofi Company 53
Testing effectiveness (Phase 2)Looking for participantsNCT05351788What this trial is testingSKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.Who this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 110
Early research (Phase 1)Study completedNCT00510445What this trial is testingStudy of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung CancerWho this might be right forLung Cancer Geron Corporation 27
Testing effectiveness (Phase 2)Ended earlyNCT02204345What this trial is testingA Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyWho this might be right forSquamous Non-Small Cell Lung Cancer Hoffmann-La Roche 12
Not applicableNot Yet RecruitingNCT07599007What this trial is testingRepotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene FusionWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06827145What this trial is testingCombination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLCWho this might be right forNon-Small-Cell Lung Cancer National Cancer Center, China 30
Testing effectiveness (Phase 2)Study completedNCT02179671What this trial is testingImmune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung CancerWho this might be right forLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) AstraZeneca 32
Testing effectiveness (Phase 2)Ended earlyNCT03666728What this trial is testingSHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLCWho this might be right forLung Neoplasms Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)Ended earlyNCT03318939What this trial is testingPhase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationWho this might be right forNSCLC Spectrum Pharmaceuticals, Inc 648
Testing effectiveness (Phase 2)Study completedNCT01529112What this trial is testingA Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different TreatmentsWho this might be right forNon-Small Cell Lung Cancer Eisai Inc. 135
Early research (Phase 1)Study completedNCT00003002What this trial is testingHER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerWho this might be right forBreast CancerLung CancerOvarian Cancer University of Washington 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05764928What this trial is testingEvaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin TherapyWho this might be right forNonsquamous Nonsmall Cell Neoplasm of Lung Rgene Corporation 32
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)UnknownNCT04467801What this trial is testingIpatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line ImmunotherapyWho this might be right forNSCLC Stage IVNSCLC Stage IIIB Jun Zhang, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT03607539What this trial is testingEfficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCWho this might be right forLung Neoplasms Innovent Biologics (Suzhou) Co. Ltd. 397